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Abstract 
X-ray crystallography on pyridazine 1 (ethyl 2-(3-methyl-4-(4-methylbenzyl)-6-oxopyridazin-
1(6H)-yl)acetate) shows the planar pyridazinyl ring to exhibit significant delocalisation of π-
electron density over the constituent atoms and to be substituted with oxo, methyl, (4-
methylphenyl)methyl and N-bound ethylacetate groups.  While three of the ring-bound atoms 
are close to co-planar with the ring, the ethylacetate group is not; the latter exhibits a 
definitive kink in its conformation.  In the molecular packing of 1, helical supramolecular 
chains along the b-axis are formed through O- and N-methylene-C–H…O(carbonyl) and O-
methylene-C–H…π(pyridazinyl) interactions.  The chains are connected into a supramolecular 
layer by π(pyridazinyl)…π(phenyl) interactions.  The flat layers stacks along the c-axis 
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without directional interactions between them.  The geometry-optimisation of 1 resulted in the 
straightening of terminal ethylacetate group but no other substantial changes.  Computational 
chemistry shows the most stabilising interactions in the crystal are due to the 
π(pyridazinyl)…π(phenyl) (-10.7 kcal/mol) followed by O- and N-methylene-C–
H…O(carbonyl) (-9.5 and -9.0 kcal/mol, respectively).  The most prominent identified inter-
layer interaction is a weak methylene-C–H···N(pyridazinyl) contact.  Throughout, 
comparisons are made with the phenyl analogue of 1, namely 2.  Most notably, the lattice 
energy of 1 is approximately 4.1 kcal/mol more stable than that of 2, an observation related to 
the influence upon the molecular packing exerted by the methyl substituent of 1.  Compound 
1 exhibits moderate inhibition against α-glucosidase, compared to Acarbose, and weak heat-
induced haemolysis inhibition. 
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1. Introduction 
Pyridazine groups are well known as an excellent nitrogen-containing heterocyclic scaffold 
owing to their extensive pharmacological and biological properties as well as numerous 
therapeutic applications in medicinal research.  Thus, they have been reported to exhibit 
different activities such as analgesic and anti-inflammatory [1-3], anti-HIV [4], anti-cancer 
[5], anti-bacterial [6], anti-fungal [7], anti-convulsant [8], cardiotonic [9], anti-ulcer [10] and 
anti-hypertensive [11,12].  Further, they have often been used as a component of a variety of 
agrochemicals such as insecticides, acaricides [13-15] and herbicides [16,17].  Given the wide 
range of therapeutic applications for pyridazine derivatives and in continuing interest in the 
synthesis of heterocyclic systems having remarkable biological potential [18-21], we have 
already reported a route for the preparation of pyridazine derivatives [22].  In addition to the 
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synthesis and spectroscopic characterisation of the new oxo-methylpyridazin derivative 
containing xylene and ethyl acetate substituents, 1, also reported are the molecular and crystal 
structure of 1 along with a Hirshfeld surface analysis and a density functional theory (DFT) 
computational study in order to gain a detailed understanding of the crucial intermolecular 
interactions operating in the crystal of 1.  Comparisons are made with the phenyl derivative of 
1, i.e. 2, in order to ascertain the influence of the methyl group in 1 upon the molecular 
packing.  Further, based on the wide biological interest of pyridazine derivatives, alluded to 
above, and due to our continuing interests on the synthesis of heterocyclic systems with 
remarkable anti-inflammatory and anti-diabetic activities [23-25], 1 was also evaluated for 
anti-inflammatory and enzyme inhibitory activities using an α-Glucosidase inhibition assay. 
 
Experimental section 
1.1. Synthesis and crystallisation of ethyl 2-(3-methyl-4-(4-methylbenzyl)-6-oxopyridazin-
1(6H)-yl)acetate (1) 
All chemicals used were of analytical grade, purchased from commercial suppliers (Sigma-
Aldrich, Merck) and used without further purification.  The melting point was obtained on a 
Büchi Melting Point SMP-20 apparatus and is uncorrected.  Infrared (IR) spectra were 
recorded with an IR VERTEX 70 FT-IR (Bruker Optics) spectrophotometer.  Nuclear 
magnetic resonance (1H and 13C{1H} NMR) spectra were recorded on a BrukerAvance (400 
MHz) spectrometer, using tetramethylsilane (TMS) as the internal standard and DMSO-d6 as 
solvent.  Mass spectra were recorded on an API 3200 LC/MS/MS mass spectrometer using 
electrospray ionization (ESI) in positive polarity. 
 
An acetic acid (50 ml) solution of 4-methylbenzaldehyde (0.01mol) and levulinic acid (0.015 
mol) was saturated with dry hydrogen chloride for 4 h followed by stirring at room 
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temperature for 24 h.  The solvent was evaporated under reduced pressure and the residue was 
washed with water and chloroform.  To the formed residue, 3-(4-methylbenzylidene)-4-
oxopentanoic acid (0.01 mol) taken in ethanol (20 ml) was added hydrazine hydrate (0.02 
mol) followed by refluxing for 2 h.  The precipitate that formed was filtered and recrystallised 
from ethanol to obtain 6-methyl-5-(4-methylbenzyl)pyridazin-3(2H)-one.  In 
dimethylformamide (500 ml), to this pyridazine (0.01 mol) was added potassium carbonate 
(0.02 mmol), tetra-n-butylammonium bromide (0.001 mmol) and 2-ethyl bromoacetate (0.02 
mol).  The mixture was stirred for 24 h at room temperature.  After this, the mixture was 
filtered and the solvent evaporated under reduced pressure.  The residue was washed with 
water and methylene chloride.  The solvent was removed and the residue was crystallised 
from its acetone solution.  The reaction scheme is shown in Scheme 1.  Colourless crystals: 
yield: 77%; M. pt: 133-135 °C.  SM (ESI+) (m/z): [M+H]+ = 301.13.  IR (cm-1): 1743.18 
(C=O, CO2Et), 1659.61 (C=ON), 1598.64 (C=C), 1204.87 (C–N), 1010.76 and 1144.87 (C-O, 
CO2Et sym and asym).  1H NMR (ppm): 1.23 (t, 3H, J= 7 .1, CH2-CH3); 2.22 (s, 3H, CH3-
Pyridazinone); 2.30 (s, 3H, CH3-phenyl); 3.85 (s, 2H, Phenyl-CH2-Pyridazinone); 4.17 (q, 2H, 
J = 7.1, O-CH2-CH3); 4.87 (s, 2H, -N-CH2-CO); 6.47 (s, 1H, Pyridazinone); 7.25-7.47 (m, 
4H, J = 3, Phenyl).  13C NMR (ppm): 14.11 (CH3); 21.03 (CH3, Pyridazinone); 22.03 (CH3, 
Phenyl); 37.67 (CH2); 51.34 (CH2); 60.95 (CH2); 127.13-127.44 (CH aromatic); 129.13-
130.35 (CH aromatic); 132.12 (C-Cα aromatic); 136.51 (CH2-C=, aromatic); 138.49 (CH, 
Pyridazinone); 144.97 (CH2-C=CH, Pyridazinone); 147.17 (C=N); 161.19 (C=O, 
Pyridazinone); 169.52 (C=O, CO2Et).  SM (ESI+), IR and NMR spectra are given in the 



























Scheme 1. Synthesis route for 1.  Compound 2, also discussed in detail in this study, is the 
phenyl analogue of 1. 
 
1.2. Single crystal X-ray structure determination 
Crystal data and refinement details are given in Table 1.  Intensity measurements for 1 were 
measured employing APEX3 [23] at T = 120 K on a Bruker Smart APEX CCD diffractometer 
equipped using Mo-Kα radiation (λ = 0.71073 Å). Data reduction was performed with SAINT 
[26] and the absorption correction was conducted with SADABS [26].  The structure was 
solved by direct methods [27] and refined (anisotropic displacement parameters and C-bound 
H atoms in the riding model approximation) on F2 [28].  A weighting scheme of the form w = 
1/[σ2(Fo2) + (0.092P)2] where P = (Fo2 + 2Fc2)/3) was introduced.  The molecular structure 
diagram was generated with ORTEP for Windows with 70% displacement ellipsoids [29] and 
the molecular packing diagrams with DIAMOND [30].  Additional analysis of the structural 
data was conducted with PLATON [31]. 
 
Table 1 
Crystal and refinement data for 1. 
Formula C17H20N2O3 
Molecular weight 300.35 
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Crystal system monoclinic 







Dx/g cm−3 1.322 
F(000) 640 
μ/mm−1 0.091 
No. reflections measured  28193 
θmax/º 29.2 
No. independent reflections 4050 
No. reflections with I ≥ 2σ(I) 3177 
R (obs. data) 0.046 
wR2 (all data) 0.136 
 
CCDC 2035086 contains the supplementary crystallographic data for this paper. These data 
can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html (or from 
the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: 
+44 1223 336033). 
 
1.3. Quantum chemical calculations 
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The gas-phase geometry optimisation calculations were performed with Gaussian 16 [32] 
using Stewart’s semi-empirical PM7 method [33] followed by the DFT-B3LYP exchange-
correlation functional coupled with Ahlrichs' valence triple-zeta polarization basis sets (def2-
TZVP) [34] with tight SCF convergence criteria applied.  Having established the optimised 
structures, the NBO analysis [35], molecular electrostatic potential (MEP) and frontier 
molecular orbital (FMO) energies were computed for the optimised structures using the same 
basis set and level of theory in which the corresponding outputs were analysed and interpreted 
through GaussView6 [36].  The condensed Fukui function [37] and relevant dual descriptor 
[38,39] were calculated using the NPA charges derived from the Gaussian program [32]. 
 
1.4. Computational modelling of intermolecular interactions 
The intermolecular interactions and contacts were analysed through CrystalExplorer17 [40] 
using the methodologies as described previously [41].  Briefly, the distances of atomic surface 
points to the nearest nucleus inside (di) and outside (de) the surface were computed and the 
resulted normalised contact distances (dnorm) were mapped onto the Hirshfeld surface in the 
range -0.0081 to 1.0105 arbitrary units.  Contact distances shorter than the sum of van der 
Waals radii are highlighted in red, while distances equal to or longer than the sum of van der 
Waals radii are, respectively, shown in white and blue [42].  The combination of di and de in 
intervals of 0.01 Å resulted in the plotting of two-dimensional fingerprint plots, where 
different colours on the fingerprint plots represent the probability of occurrence, ranging from 
blue (few points) to green (moderate) and red (many points) [43].  All hydrogen atom bond 
lengths were normalised to the standard neutron values prior to the analysis. 
 
Upon the identification of close contacts in the Hirshfeld surface analysis, various qualitative 
and quantitative computations were then performed to study the strength of all identified 
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pairwise interacting molecules.  The qualitative analysis was achieved through NCIPLOT 
[44] by plotting the reduced density gradient as a function of density across the molecules. 
The computed density derivatives were mapped as iso-surfaces which correspond to any 
favourable or unfavourable interactions as determined by the sign of the second density 
Hessian eigenvalue times the density [45].  The program VMD Molecular Graphics Viewer 
[46] was used to visualise the non-covalent interaction index.  As for the quantitative analysis, 
the interaction energies were computed using the optimised CE-B3LYP/6-31G(d,p) model as 
available in CrystalExplorer17 [40], in which the corresponding energy was obtained by 
summing up four energy components comprising the electrostatic (Eele), polarization (Epol), 
dispersion (Edis) as well as exchange-repulsion (Erep) energies with scale factors of 1.057, 
0.740, 0.871 and 0.618, respectively [47,48].  A similar method was applied in the simulation 
of energy frameworks and calculation of the lattice energy for the crystals.  The energy 
frameworks comprising Eele, Edis and Etotal were generated for a cluster of 2 × 2 × 1 unit-cells 
with the energy cut-off being set to 1.9 kcal/mol, whereas the lattice energy was calculated for 
a cluster of molecules within a 25 Å radius from a selected central molecule using equation 
(1): 
 
Elattice = ½ ∑ E ABtotal                 (1) 
 
Where A is the central molecule, B are the molecules surrounding A, and RAB is the 
separation of the molecular centroids within a radius of RAB defined by the molecular 
centroids [49]. 
 
1.5. Biological assays 
1.5.1. Enzyme inhibitory activity: α-Glucosidase inhibition assay 
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The α-glucosidase inhibitory activity was performed in phosphate buffered saline PBS (0.1 M 
KH2PO4–K2HPO4, pH 6.7), using 4-nitrophenyl-α-D-glucopyranoside (ρNPG) as the 
substrate according to the method described by Kee et al. [50], with some modifications.  All 
tested extracts were dissolved in phosphate buffered saline (PBS) to a series of different 
concentrations.  Briefly, a mixture of 150 μL of the sample and 100 μL of phosphate buffered 
saline (PBS) containing the enzyme α-glucosidase solution (0.1 U/mL) were incubated at 37 
°C for 10 min.  Then, 200 μL 4-nitrophenyl-α-D-glucopyranoside (1 mM) was added to the 
mixture to initiate the reaction.  After further incubation at 37 °C for 30 min, 600 μL Na2CO3 
(0.1 M) was added and the absorbance was measured at 405 nm on a UV/vis 
spectrophotometer. 
Two concentrations were tested for 1: 45.0 and 22.5 mM/l.  The standard, Acarbose, was used 
as the positive control. 
 
The results were expressed as percentage inhibition and calculated using the following 
formula (2): 
Inhibition (%) = [1−(Asample – Absample)/(Acontrol – Abcontrol)] × 100               (2) 
where: 
− Acontrol refers to the absorbance of control (enzyme and buffer) 
− Abcontrol refers to the absorbance of control blank (buffer without enzyme) 
− Asample refers to the absorbance of sample (enzyme and inhibitor) 
− Absample is the absorbance of sample blank (inhibitor without enzyme) 
 
1.5.2. In vitro anti-inflammatory study 
Preparation of erythrocyte suspension 
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A suspension of erythrocytes was prepared by the method described by Shinde et al. [51] with 
some modifications. 
A sample of fresh whole human blood was obtained from a healthy human volunteer at the 
National Blood Transfusion Center of Rabat, Morocco, in January 2019.  Serological tests 
were performed and proved negative. 
Whole human blood was transferred to heparinised centrifuge tubes, centrifuged at 3000 rpm 
for 5 min and the supernatants (plasma and leucocytes) were carefully removed while the 
packed red blood cell was washed three times with equal volume of normal fresh saline (0.9% 
w/v NaCl). 
The volume of the blood was measured and reconstituted as a 40% (v/v) suspension with 
isotonic buffer solution (10 mM sodium phosphate buffer pH 7.4). 
The composition of the buffer solution (g/l) was NaH2PO4 (0.2), Na2HPO4 (1.15) and NaCl 
(9.0) [52]. 
Heat-Induced haemolysis assay 
This test was carried out as described by Okoli et al. [53] and Ranasinghe et al. [54]. The 
isotonic buffer solutions (5 ml) containing 1000, 500 and 250 μg/ml of 1 were put in 5 sets of 
centrifuge tubes (per concentration).  The negative control tubes contained 5 ml of the vehicle 
and positive control tubes contained 100 μg/ml of Indomethacin in 5 ml total volume.  The 
erythrocyte suspension (0.05 ml) was added to each tube and gently mixed.  A pair of the 
tubes was incubated at 54 °C for 20 min. in a regulated water bath.  At the end of the 
incubation, the reaction mixture was centrifuged at 1300 g for 3 min and the absorbance (OD) 
of the supernatant measured at 540 nm [6], using a UV-VIS Spectrophotometer UV-1100. 
 
The level of inhibition of haemolysis was calculated using the following relation (3): 
% inhibition of haemolysis = [(A Control – A sample) / A Control] × 100               (3) 
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2. Results and Discussion 
2.1. X-ray crystallography 
The molecular structure of 1 is shown in Fig. 1 and comprises a central pyridazinyl ring 
substituted with oxo, methyl, (4-methylphenyl)methyl and N-bound ethylacetate groups.  The 
six-membered ring is planar, exhibiting a r.m.s. of the fitted atoms of 0.0032 Å.  Of the four 
ring-bound substituents, only the C5 atom of the ethylacetate group lies significantly 
[0.1282(16) Å] out of the plane through the pyridazinyl ring.  Selected geometric parameters 
are collated in Table 2.  Formally, the C1–N2 and C2–C3 bonds are double-bonds but, the 
lengthening of these bonds, coupled with the lengthening of the C4–N1 bond, and 
concomitant shortening of the N1–N2, C1–C2 and C3–C4 bonds along with the lengthening 
of the exocyclic C4–O1 bond, compared with standard bond lengths, suggests considerable 
delocalisation of π-electron density over the oxopyridazinyl part of the molecule.  The 
pendent 4-tolyl ring lies in a position folded towards and almost orthogonal to the plane of the 
central with the dihedral angle between the least-squares being 81.92(3)°.  Similarly, the 
carboxylate residue is inclined to the central ring but, to the opposite side, with the C4N2/CO2 
dihedral angle = 77.98(9)°.  The C6–O3–C7–C8 torsion angle of -98.20(11)° is indicative of 
an -anti-clinal conformation. 
 
Fig. 1.The molecular structure of 1, showing the atom-labelling scheme and displacement 





Selected geometric (Å, °) parameters for 1 and 2, as determined by X-ray crystallography, and 
1g and 2g, from the gas-phase DFT calculations 
Parameter 1 1g 2 2g 
N1–N2 1.3645(12) 1.340 1.3625(10) 1.339 
C1–N2 1.3072(14) 1.300 1.3063(11) 1.300 
C4–N1 1.3827(13) 1.400 1.3845(12) 1.400 
C1–C2 1.4434(14) 1.446 1.4463(12) 1.446 
C2–C3 1.3517(15) 1.354 1.3535(13) 1.354 
C3–C4 1.4423(15) 1.445 1.4434(12) 1.445 
C4–O1 1.2354(13) 1.224 1.2336(11) 1.224 
C4N2/CO2 77.98(9) 88.8 77.48(3) 88.6 
C4N2/aryl 81.92(3) 88.7 76.94(3) 88.8 
N2–N1–C5–C6 120.40(10) 93.0 104.33(9) 93.4 
N1–C5–C6–O3 154.25(9) 173.3 176.15(7) 172.9 
C5–C6–O3–C7 174.64(9) 179.6 176.99(8) 179.5 
C6–O3–C7–C8 -98.20(11) 179.3 -172.44(8) 179.2 
 
The closest literature precedent to 1 is a species where the 4-tolyl group of 1 is now a phenyl 
group, hereafter 2 [22], see Scheme 1.  As seen from Table 2, the key geometric parameters 
for both molecules are equal within experimental error with any notable differences between 
the molecules being conformational in nature.  Thus, the C4N2/4-tolyl dihedral angle in 1 of 
81.92(3)° is wider than the analogous C4N2/phenyl dihedral of 76.94(3)° in 2 [22].  More 
dramatic are the differences in the C6–O3–C7–C8 torsion angles of -98.20(11) and -
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72.44(8)°, respectively, with the latter being indicative of an -anti-periplanar conformation 
rather than the -anti-clinal conformation observed in 1. 
 
2.2. Molecular packing 
The key feature of the molecular packing of 1 is the formation of supramolecular chains along 
the b-axis, being propagated by 21-screw symmetry, Fig. 2(a); details of the identified 
intermolecular interactions are given in the caption to the figure.  The chains feature 
methylene-C–H…O(carbonyl) interactions with the donor atoms being O- and N-bound 
methylene and the acceptor being the ring-carbonyl atom implying this atom is bifurcated.  
Additional stabilisation to the chain is provided by O-methylene-C–H···π(pyridazinyl) 
interactions.  The chains are connected into a supramolecular layer parallel to (-1 0 1) by 
π(pyridazinyl)···π(phenyl) interactions, Fig. 2(b); the layer has a flat topology, Fig. 2(c).  The 
layers stack along the c-axis without directional interactions between them according to the 
standard distance criteria [31]. 
 
Fig. 2.  Molecular packing in the crystal of 1: (a) supramolecular chain sustained by C–H···O 
contacts, shown as orange dashed lines, (b) supramolecular layer parallel to (-1 0 1) with C–
H…π and π…π interactions shown as purple and blue dashed lines, respectively, (c) a side-on 
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view of the layer shown in (b) and (d) a view of the unit-cell contents in projection down the 
a-axis.  In (a)-(c), non-participating hydrogen atoms are omitted for reasons of clarity.  
Intermolecular contacts: C5–H5b···O1i: H5b…O1i = 2.44 Å, C5…O1i = 3.3284(14) Å and 
angle at H5b = 150°; C7–H7a···O1ii: H7a…O1ii = 2.45 Å, C7…O1ii = 3.1761(14) Å and angle 
at H7a = 130°; C7–H7b···Cg(N1,N2,C1-C4)iii: H7b···Cg(N1,N2,C1-C4)iii = 2.99 Å, 
C7···Cg(N1,N2,C1-C4)iii = 3.7776(13) Å and angle at H7b = 138°; Cg(N1,N2,C1-
C4)···Cg(C11-C16)iv = 3.8258(6) Å, angle of inclination = 15.73(5)°.  Symmetry operations: 
(i) 1-x, 1-y, 1-z; (ii) 1-x, -y, 1-z, (iii) x, -1+y, z; (iv) ½-x, -½+y, ½-z.   
 
There is a clear distinction in the mode of association between molecules in each of 1 and 
phenyl analogue, 2.  In the latter, the N-methylene group is pivotal in that both hydrogen 
atoms are engaged in the formation of a supramolecular tape via C–H···O(ring carbonyl) and 
C–H…N(pyridazinyl) interactions as shown in Fig. 3.  A three-dimensional architecture arises 
as the tapes are linked by a combination of methyl- and phenyl-C–H···O(ring carbonyl) and 
phenyl-C–H···O(ester carbonyl) interactions. 
 
 
Fig. 3.  A view of the supramolecular tape in the crystal of 2 sustained by C–H···O(ring 





2.3. Theoretical molecular structures 
Molecule 1 was subjected to gas-phase geometry-optimisation and the optimised structure, 
hereafter 1g, was subsequently validated by a vibrational frequency analysis showing the 
result corresponds to a local minimum structure with zero imaginary frequency.  Selected 
geometric data for the optimised structure are included in Table 2 for comparison with those 
determined for the experimental structure of 1.  An image showing the superimposition of the 
experimental and theoretical structures for 1 is shown in Supplementary Materials Fig. S5 
which reveals that there has been a major adjustment in the optimised molecule in that the 
orientation of the ethylacetate residue is in close alignment with pseudo-mirror plane of the 
pyridazinyl ring.  The conformational differences are quantified in the dihedral angles 
between the central pyridazinyl and 4-tolyl rings which compute to 81.92(3)° for 1 and 87.9° 
for 1g.  The connection between the ring and ethylacetate group also presents significant 
differences as seen in the N2–N1–C5–C6, i.e. 120.40(10) and 91.9° for 1 and 1g, respectively, 
and N1–C5–C6–O3 torsion angles, i.e. 154.25(9) and 174.6°, respectively. 
 
Geometry-optimisation was also performed on 2 to yield theoretical structure 2g.  The 
geometric parameters for 2g are included in Table 2 and the molecular conformations for 2 
and 2g are also shown in Supplementary Materials Fig. S5, indicating no striking differences 
occurred upon geometry-optimisation.  From the data in Table 2, it is clear no significant 
differences are apparent between the gas-phase molecules of 1g and 2g in terms of geometric 
parameters and molecular conformations.  For 1/1g, the RMSD for the molecules came to 
0.388 Å and for 2/2g a smaller value was obtained, i.e. 0.224 Å. 
 
2.4. Prediction of molecular reactivity 
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Several strategies were employed to study the molecular reactivity of 1, which include 
molecular electrostatic potential mapping (MEP), natural population analysis (NPA), 
condensed Fukui functions and dual descriptor calculation, natural bond orbital (NBO) 
analysis as well as frontier molecular orbital energy calculations.  For meaningful evaluation 
of the computed data, a comparison was made with the closely related structural analogue, 
with the phenyl ring rather than 4-tolyl group, i.e. 2 [22]. 
 
The MEP mapping was performed on the optimised structures to ascertain the electropositive 
and electronegative sites in 1 and 2 with the aim of ascertaining any influence of the methyl 
substituent in 1 upon the overall electrostatic potential of the molecule compared with 2.  As 
expected, an intense red region is observed for the oxo-O1 atom in each molecule, being 
reflective of electronegative oxygen centre, Fig. 4.  Similar observations are noted for the 
other heteroatoms, namely the carboxylic acid-O2 and -O3 atoms as well as the hydrazine-
N1- and -N2 atoms, albeit with reduced intensity.  In general, there are no significant 
deviations in the calculated electrostatic potentials in the pyridazinyl and ethylacetate 
fragments between 1 and 2.  The electron-donating effect of the methyl substituent is barely 
observed on the phenyl ring: the electrostatic potential of the adjacent C14 is slightly reduced 
to -0.011 a.u. in 1 compared to -0.016 a.u. in unsubstituted 2.  Due to the weak inductive 
effect of the methyl group [55], 1 is found to possess slightly more negative electrostatic 





Fig. 4.  The overall three-dimensional MEP maps (top) as well as the two-dimensional 
contour plot (iso-density value = 0.004 a.u.) as projected on the central pyridazinyl (middle) 
and benzene rings (bottom) along with the total cumulative electrostatic charges for (a) 1 and 
(b) 2.  The contour plots for the ethylacetate fragment were omitted owing similar total 
cumulative electrostatic charges between the two molecules. 
 
The NPA analysis was performed to estimate the partial charges on atoms and to gain further 
insight into the electronic charge distribution within the molecules, in particular for the phenyl 
ring fragments so as to evaluate the effect of the methyl substituent in 2.  NPA was chosen for 
the charge calculation as this approach has been reported to give reliable results while being 
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less sensitive to the choice of basis set functions [56], despite it may not be suitable for ionic 
clusters [57].  The atomic charges for all non-hydrogen atoms are collated in Table 2.  From 
the data, it can be observed that the central pyridazinyl ring and ethylacetate fragment in both 
1 and 2 exhibit no significant charge deviations, with the O1 atom being the most basic atom 
among all.  For the other heteroatoms, the electronegativity decreased in the order O2 > O3 > 
N2 > N1.  More notable differences were evident for the substituted phenyl ring.  Thus, the 
C14 atom exhibits relatively less negative charge (-0.019 vs -0.207 e) in 1 compared to 2, 
while the opposite trend, albeit less dramatic, is true for the C11 atom (-0.035 vs -0.023 e).  
Overall, the majority of phenyl carbons in 2 have reduced electronegativity compared to their 
counterparts in 1 with the net charge shift, [∑q(C6H4)2 - ∑q(C6H5)1] [56], being -0.030 e 
indicating that the methyl substituent is withdrawing electron-density, consistent with 
expectation [58,59]. 
 
To complement the NPA analysis, 1 and 2 were also subjected to condensed Fukui function 
calculation based on Parr and Yang’s conceptual density theory (CDFT) [60-62] which are 
expressed in the following equations (4)-(6) [37]: 
 
    For nucleophilic attack: f+k = qk(N + 1) – qk(N)   (4) 
    For electrophilic attack: f–k = qk(N) – qk(N – 1)   (5) 
    For radical reaction: f0k = ½[qk(N + 1) – qk(N – 1)]   (6) 
 
In the equations, qk represents the atomic charges of kth atom in the neutral (N), cationic (N – 
1) and anionic (N + 1) states in a frozen orbital approximation.  According to the theory, the 
higher value of f indicates a greater propensity for the reaction to occur at the activated site of 
the molecule [37].  Nevertheless, the interpretation of the data is not always straightforward, 
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particularly for negative Fukui function values which can be associated with orbital relaxation 
effects [63].  In this context, the dual descriptor (equation 7) [38,39] offers an unambiguous 
description on the nucleophilic and electrophilic behaviour of the active sites within a 
molecule without being affected by relaxation effects [64]. 
 
Δf(k) = f+k – f
–
k    (7) 
 
The nucleophilic and electrophilic behaviour is determined by the sign of the dual descriptor, 
whereby Δf> 0 signifies a favourable site for nucleophilic attack while Δf< 0 represents a 
favourable site for electrophilic attack [38,39].  In line with the MEP analysis, the O1, O2, 
O3, N1 and N2 atoms in each of 1 and 2 exhibit negative dual descriptor values indicating 
that they are nucleophilic in nature and inclined for electrophilic attack (Table 3).  Amongst 
these atoms, the carbonyl-O1 atoms has the lowest dual descriptor value suggesting that they 
have the greatest propensity for electrophilic attack.  On the other hand, an influence due the 
methyl substituent upon the phenyl ring is noted, whereby the C14 atom in 1 exhibits a 
positive sign for the dual descriptor in contrast to the negative sign for 2.  This signifies that 
the former has a greater probability for nucleophilic attack while the opposite is true for the 
latter.  This observation is consistent with the MEP and NPA charges for the corresponding 
atoms which can be rationalised in terms of the inductive effect.  As expected, the methyl 
substituent exerts little influence over the remaining part of the molecule as no apparent 
trends in the signs of the dual descriptor are evident. 
 
Table 3 
Comparison of NPA charge, condensed Fukui functions (f- and f+) and dual descriptor (Δf) for 
all non-hydrogen atoms in 1 and 2, all units are in electron, |e|.a 
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Atom 1 2 
 NPA f- f+ Δf NPA f- f+ Δf 
O1 -0.614 -0.090 -0.213 -0.123 -0.613 -0.089 -0.216 -0.127 
O2 -0.577 -0.012 -0.020 -0.008 -0.573 -0.011 -0.026 -0.015 
O3 -0.483 -0.016 -0.018 -0.002 -0.484 -0.015 -0.016 -0.001 
N1 -0.189 -0.065 -0.100 -0.035 -0.188 -0.067 -0.114 -0.047 
N2 -0.196 -0.048 -0.163 -0.115 -0.195 -0.052 -0.165 -0.113 
C1 0.159 -0.031 -0.096 -0.065 0.158 -0.031 -0.114 -0.083 
C2 0.013 -0.135 -0.007 0.128 0.012 -0.136 -0.013 0.123 
C3 -0.242 -0.191 -0.064 0.127 -0.242 -0.193 -0.082 0.111 
C4 0.566 0.012 0.024 0.012 0.566 0.012 0.031 0.019 
C5 -0.317 0.007 0.012 0.005 -0.316 0.009 0.012 0.003 
C6 0.767 -0.007 0.005 0.012 0.768 -0.015 0.003 0.018 
C7 -0.077 0.001 0.003 0.002 -0.070 0.000 0.003 0.003 
C8 -0.618 0.002 0.002 0.000 -0.608 0.003 0.004 0.001 
C9 -0.620 0.014 0.020 0.006 -0.620 0.015 0.024 0.009 
C10 -0.436 0.020 0.017 -0.003 -0.437 0.020 0.009 -0.011 
C11 -0.035 0.046 -0.053 -0.099 -0.023 0.041 -0.068 -0.109 
C12 -0.194 -0.005 -0.019 -0.014 -0.203 -0.001 -0.025 -0.024 
C13 -0.196 -0.018 -0.045 -0.027 -0.195 -0.019 -0.052 -0.033 
C14 -0.019 -0.026 -0.012 0.014 -0.207 -0.025 -0.086 -0.061 
C15 -0.197 -0.016 -0.031 -0.015 -0.196 -0.018 -0.035 -0.017 
C16 -0.195 -0.007 -0.024 -0.017 -0.204 -0.006 -0.039 -0.033 
C17 -0.610 0.009 0.017 0.008 - - - - 
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a The condensed Fukui function for the radical reaction term (f0) is omitted from the 
comparison. 
 
2.5. Natural bond orbital (NBO) analysis 
Apart from NPA charge analysis, values for the Wiberg bond index [65] were obtained 
through an NBO analysis in order to assess the electron population overlap between pairs of 
atoms.  The results are collated in Table 4 and show that the Wiberg index is almost the same 
for comparable pairs of atoms in 1 and 2.  The only notable exceptions are for the C13–C14 
and C14–C15 bonds for which the indices are smaller in 1 when compared to 2, indicating 
that the methyl substituent withdraws some of the electron population from these bonds, again 




A comparison of Wiberg bond orders for all non-hydrogen bonds in 1 and 2. 
Bond Wiberg index 
1 2 
O1–C4 1.800 1.791 
O2–C6 1.874 1.877 
O3–C6 0.944 0.945 
O3–C7 0.977 0.979 
N1–C4 0.936 0.942 
N1–N2 0.977 0.976 
N1–C5 0.981 0.981 
N2–C1 1.778 1.786 
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C1–C2 0.965 0.968 
C1–C9 0.981 0.979 
C2–C3 1.789 1.794 
C2–C10 0.972 0.971 
C3–C4 0.959 0.959 
C5–C6 0.943 0.944 
C7–C8 0.990 0.991 
C10–C11 0.980 0.979 
C11–C12 1.629 1.632 
C12–C13 0.984 0.983 
C13–C14 1.628 1.653 
C14–C15 0.977 0.985 
C15–C16 1.655 1.651 
C16–C11 0.977 0.980 
C14–C17 0.986 – 
 
The interpretation of hyper-conjugative or delocalisation of electron density between 
occupied Lewis-type NBO orbitals (i.e. donors) and unoccupied non-Lewis NBO orbitals (i.e. 
acceptors) was also achieved through an NBO analysis by estimating the stabilisation energy 
E2 using the second order perturbation theory, in which a larger value of E2 represents a 
stronger electron donor-acceptor interaction [66].  Selected donor-acceptor interactions with 
significant stabilisation energy (E2> 10 kcal/mol) are collated in Table 5.  From these data, a 
clear differentiation is observed in the stabilisation energies of the phenyl rings in 1 and 2, 
where the former exhibits slightly greater values of E2 (~1 to 2 kcal/mol).  This result 
indicates that is an increase of electron-delocalisation within the phenyl ring which can be 
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traced to the influence of the methyl substituent in 1.  Overall, there is little deviation in E2 
observed for the pyridazinyl rings and ethylacetate fragments in 1 and 2.  Among all the 
donor-acceptor interactions, the N1 LP (1) → π*(O1–C4) and LP (2) O3 → π*(O2–C6) 
transitions exhibit the greatest stabilisation energies of ~58 and ~51 kcal/mol, respectively. 
 
Table 5 
A comparison of the second order perturbation energies, E2 for selected bonding (E2> 10 
kcal/mol) between 1 and 2.a 
Donor Type Acceptor Type Stabilisation Energy, E2 
(kcal/mol) 
1 2 
N1 LP (1) O1–C4 BD* (2) 57.62 57.94 
O3 LP (2) O2–C6 BD* (2) 51.25 51.78 
N1 LP (1) N2–C1 BD* (2) 33.49 33.17 
O2 LP (2) O3–C6 BD* (1) 33.47 33.05 
O1 LP (2) N1–C4 BD* (1) 31.27 29.32 
O2 LP (2) C5–C6 BD* (1) 23.78 23.93 
C2–C3 BD (2) O1–C4 BD* (2) 22.68 22.38 
C15–C16 BD (2) C11–C12 BD* (2) 22.16 21.42 
C13–C14 BD (2) C15–C16 BD* (2) 21.70 20.89 
C11–C12 BD (2) C13–C14 BD* (2) 22.45 20.17 
C15–C16 BD (2) C13–C14 BD* (2) 21.18 19.50 
C11–C12 BD (2) C15–C16 BD* (2) 21.65 19.37 
C13–C14 BD (2) C11–C12 BD* (2) 20.36 19.15 
O2 LP (1) C6 RY* (1) 18.71 18.27 
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O1 LP (2) C3–C4 BD* (1) 18.51 18.30 
C2–C3 BD (2) N2–C1 BD*(2) 18.37 18.87 
O1 LP (1) C4 RY* (1) 16.10 15.70 
N2 LP (1) C1–C2 BD* (1) 12.02 11.61 
N2 LP (1) N1–C4 BD* (1) 11.98 11.02 
N2–C1 BD (2) C2–C3 BD* (2) 11.01 10.94 
a LP denotes a lone-pair; BD a two-centre bond; BD* a two-centre anti-bonding; RY* a one-
centre Rydberg 
 
2.6. Frontier molecular orbital analysis 
A frontier molecular orbital analysis was performed to complement the condensed Fukui 
function and dual descriptor calculations in predicting the chemical reactivity of 1 and 2.  The 
plots of the Highest Occupied Molecular Orbital (HOMO) and Lowest Unoccupied Molecular 
Orbital (LUMO) of 1 and 2 from the ground state (S0) to the first excitation state (S1) are 
presented in Supplementary Materials Fig. S6.  From the mapping, it can be observed that the 
HOMO electrons are mainly delocalised on the carbonyl-O1 atom while the LUMO electrons 
are delocalised over the N2–C1 atoms in the pyridazinyl ring with the energy gap being 
0.2405 eV for each of 1 and 2.  Hence, it can be concluded that the methyl group in 1 has little 
effect upon the overall reactivity of the molecule. 
 
2.7. Theoretical studies for intermolecular interactions 
The intermolecular contacts identified for the crystal of 1 were studied both qualitatively and 
quantitatively to better understand the nature of the interactions that contribute to the packing 
pattern. Several approaches such as Hirshfeld surface analysis, non-covalent interaction plots, 
interaction energy calculations, energy framework simulation as well as crystal lattice energy 
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calculations were employed for the study.  A complementary analysis on 2 was used for 
comparison whenever relevant. 
 
2.8. Hirshfeld surface analysis 
Several close contacts were identified through the Hirshfeld surface analysis as revealed by 
the presence of red spots of varying intensity on the surface maps shown in Fig. 5, being 
indicative of contact distances shorter than the sum of van der Waals radii [42].  With the 
absence of conventional hydrogen bonds, the most intense red spots are observed for the 
methylene-C5–H5b···O1(carbonyl) and methylene-C7–H7a···O1(carbonyl) contacts with 
corresponding dnorm contact distances of 2.36 and 2.39 Å, respectively, which are about 0.25 
and 0.22 Å shorter than the H···O van der Waals radii of 2.61 Å (adjusted to neutron values), 
Table 6.  Other noticeable contacts with relatively less intensity, which range from diminutive 
red to white spots arise due to C1···C13, methyl-C9–H9c···O2(carbonyl) as well as 
methylene-C5–H5a···N2(pyridazinyl) contacts with the dnorm distances being 3.37, 2.59 and 
2.64 Å, respectively, which are marginally shorter than or equivalent to their corresponding 
van der Waals radii.  The aforementioned methylene-C5–H5a···N2(pyridazinyl) contacts 






Fig. 5. Perspective views of the dnorm map for 1, showing relevant short contacts indicated by 
the red spots on the Hirshfeld surface with varying intensities within the range of -0.0081 to 




A summary of the dnorm contact distances (adjusted to neutron values) for interactions present 
in 1, as computed through a Hirshfeld Surface analysis.a 
Contact Distance (Å) ∑vdW (Å) Δ|dnorm - ∑vdW| 
(Å) 
Symmetry Operation 
H5b···O1 2.36 2.61 0.25 1-x, 1-y, 1-z 
H7a···O1 2.39 2.61 0.22 1-x, -y, 1-z 
C1···C13 3.37 3.40 0.03 ½-x, -½+y, ½-z 
H9c···O2 2.59 2.61 0.02 x, 1+y, z 
H5a···N2 2.64 2.64 0.00 -x, 1-y, 1-z 
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H10a···H12 2.18 2.18 0.00 ½-x, ½+y, ½-z 
a ∑vdW = sum of the respective van der Waals 
 
Having identified the interaction between the C1 and C13 atoms, Table 6 and Fig. 5, this close 
contact was further established through the plotting of the Hirshfeld surface over the 
curvedness which reveals that the presence of this interaction is supported by shape 
complementarity between the pyridazinyl and phenyl rings, Fig. 6a.  A similar finding is also 
noted for the additional π-contact involving the pyridazinyl ring and methylene-C7–H7b 
atom, as evidenced through the complementary concave and convex shapes between the 
centre of the ring and the H7b atom, Fig. 6b. 
 
Fig. 6. (a) The Hirshfeld surface mapped with curvedness (property range: -4.0 to +0.4 
arbitrary units) for π(N1-C4)···π(C11-C16) and (b) Hirshfeld surface mapped with the shape 
index property (range: -1.0 to +1.0 arbitrary units) for the pyridazinyl ring (highlighted by the 




The quantification of the corresponding close contacts was achieved through an analysis of 
the full and delineated two-dimensional fingerprint plots, Fig. 7, which shows that the 
distribution of contacts on the Hirshfeld surface of 1 is dominated by H···H (55.7%) contacts 
followed by H···O/O···H (21.5%), H···C/C···H (12.9%) and H···N/N···H (6.4%) contacts.  
The corresponding minimum di + de peaks for H···H, H···O/O···H, H···C/C···H and 
H···N/N···H are attributed to the H10a···H12 (di + de ~ 2.16 Å), O1···H5b (di + de ~ 2.36 Å), 
C4···H5b (di + de ~ 2.86 Å) and N2···H5a (di + de ~ 2.64 Å) contacts.  Overall, the 
heterogeneous contacts are slightly inclined towards (internal)-X···H-(external), Fig. 7, 
reflecting the lack of molecular symmetry in 1 coupled with the observation that hydrogen 
accepting atoms are dominant over hydrogen donor atoms.  A comparison of the contact 
distribution between 1 and 2, Table 7, shows that generally there is not much deviation 
between the patterns of surface contacts, with the latter exhibiting a slightly greater 
distribution in the heterogeneous contacts compared to the former. 
 
 
Fig. 7.  (a) The overall two-dimensional fingerprint plot for 1 as well as those delineated into 
(b) H···H, (c) H···O/O···H, (d) H···C/C···H and (e) H···N/N···H contacts, with the 
prominent tips of the fingerprint plot corresponding to the relevant contacts highlighted on the 





A comparison of the percentage distributions of close Hirshfeld surface contacts in 1 and 2. 
Contact    % distribution of close contact 
1 2 
H···H 55.7 52.2 
H···O/O···H 21.5 23.3 
H···C/C···H 12.9 14.7 
H···N/N···H 6.4 6.6 
Other 3.5 3.2 
 
2.9. Interaction energy calculations 
The strength of all close contacts in the crystal of 1 was assessed quantitatively by the 
calculation of the corresponding interaction energies.  As shown in Table 8, the π···π 
interaction involving the pyridazinyl and phenyl ring is found to have the greatest interaction 
energy among all pairwise interactions with the Etotal being -10.7 kcal/mol, an energy within 
the range -1.0 to -15.1 kcal/mol normally found for π···π interactions [64].  The pairwise C7–
H7a···O1 and C5–H5b···O1 interactions constitute next strongest interactions with Etotal being 
-9.5 and -9.0 kcal/mol, respectively.  As expected, the inter-layer C5–H5a···N2 interaction 
displays an Etotal of -6.5 kcal/mol which is less compared with the C–H···O counterpart due to 
the relatively reduced electrostatic potential in the nitrogen atom, compared to oxygen, as 
shown from the MEP mapping. 
 
The phenyl analogue 2, exhibits comparable interactions which are equivalent to π(N1,N2,C1-
C4)···π(C11-C16), C5–H5b···O1, C7–H7b···π(N1,N2,C1-C4) and C5–H5a···N2 interactions 
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in 1, with the corresponding Etotal values being -9.3, -5.9, -2.7 and -7.1 kcal/mol, respectively, 
Table 8.  Interestingly, it can be observed that the π···π interaction in 2 is slightly weaker in 
energy than that in 1 which may be related to the increased electron delocalisation in the 
methylated-phenyl ring in 1 as evidenced through the NBO and frontier molecular orbital 
analyses.  As a result, 1 exhibits slightly stronger π···π interaction than 2 by ~1.4 kcal/mol 
with a concomitant decrease in the respective centroid-to-centroid distances from 3.9573(7) Å 




Interaction energies (kcal/mol) for close contacts present in 1 and 2. 
Close contact Eele Epol Edis Erep Etotal Symmetry 
operation 
1       
π(N1,N2,C1-
C4)···π(C11-C16) +  
-3.4 -1.0 -11.8 5.5 -10.7 ½-x, -½+y, ½-z 
H10a···H12       
{C7–H7a···O1}2 -6.1 -1.9 -5.9 4.3 -9.5 1-x, -y, 1-z 
{C5–H5b···O1}2 -4.0 -1.3 -8.5 4.7 -9.0 1-x, 1-y, 1-z 
C9–H9c···O2 +  
C7–
H7b···π(N1,N2,C1-C4) 
-3.4 -0.8 -6.6 2.7 -8.1 x, 1+y, z 
{C5–H5a···N2}2 -3.5 -0.3 -6.7 4.1 -6.5 -x, 1-y, 1-z 
       





-3.3 -1.0 -9.9 4.9 -9.3 1½-x, ½+y, ½-z 
{C5–H5b···O1}2 -2.8 -0.7 -4.3 2.0 -5.9 1-x, 1-y, 1-z 
C7–
H7b···π(N1,N2,C1-C4) 
0.3 -0.4 -3.9 1.3 -2.7 x, 1+y, z 
{C5–H5a···N2}2 -5.0 -0.5 -7.6 6.1 -7.1 2-x, 1-y, 1-z 
 
 
2.10. Non-covalent interaction (NCI) plots 
The NCI plot calculations were performed to complement the quantitative energy 
calculations.  The results demonstrate the π(N1,N2,C1-C4)···π(C11-C16) interaction 
manifests as a relatively high-density, localised domain between the π-rings that further 
extends to nearby atomic clusters, Fig. 8a.  It could be for this reason that the π···π contact 
exhibits a relatively high Etotal compared to the rest of the contacts in the molecule.  Similar 
observations are found for C7–H7a···O1 (Fig. 8b) and C5–H5b···O1 (Fig. 8c) for which an 
extended domain is noted on the neighbouring atoms despite the relatively smaller sizes of the 
domains as compared to that for the π···π interaction.  The NCI plots for the C9–H9c···O2 + 
C7–H7b···π(N1,N2,C1-C4) and inter-layer C5–H5a···N2 interactions, shown in Fig. 8d and 
8e, respectively, mainly comprise small domains and thereby contribute relatively smaller 
Etotal values.  Overall, all intermolecular interactions present in 1 are considered weak but 
attractive in nature with the reduced density being in the range of -0.05 < sign(λ2)ρ < 0.05 a.u. 
as shown in the corresponding two-dimensional reduced density gradient versus the density 
plots.  The intramolecular H7b···O2 contact is the only interaction that shows a strong 





Fig. 8. The non-covalent interaction plots and corresponding RDG versus sign(λ2)ρ plots for 
(a) π(N1,N2,C1-C4)···π(C11/C16), (b) C7–H7a···O1, (c) C5–H5b···O1, (d) C9–H9c···O2 + 
C7–H7b···π(N1,N2,C1-C4) and (e) inter-layer C5–H5a···N2 interactions. 
 
3.11 Energy framework simulation and crystal lattice energy calculation 
With the absence of conventional hydrogen bonds, the crystal of 1 is governed primarily by 
dispersion forces mainly attributed to the π···π and other weak interactions.  As shown in Fig. 
9, this leads to a shield-like dispersion force topology which supersedes the electrostatic 
forces.  The combination of the electrostatic and dispersion forces leads to the same topology 





Fig. 9. The calculated energy frameworks for 1 and 2 as viewed along the a-axis, showing the 
(a) electrostatic force (red cylinders), (b) dispersion force (green) and (c) total energy (blue) 
diagrams.  The cylindrical radius is proportional to the relative strength of the corresponding 
energies and they were adjusted to the same scale factor of 150 with a cut-off value of 1.9 
kcal/mol within a 2 × 2 × 1 unit-cells. 
 
 The crystal of 2 exhibits a similar topographical profile as for 1 owing to their 
comparable molecular packing.  Nevertheless, the greater electrostatic and dispersion forces 
are evident in 1 compared to 2 as can be discerned from the relatively thicker energy 
frameworks suggesting that greater stabilisation energy exists in 1.  These qualitative 
observations are vindicated by quantitative lattice energy calculations which confirm the 
lattice energy calculated for 1, i.e. -29.9 kcal/mol, is about 4.1 kcal/mol more stable than that 
calculated for 2, Table 9.  This suggests the inclusion of methyl substituent in the structural 




The lattice energy (Elattice) and the corresponding energy components (Eelectrostatic, Epolarization, 
Edispersion and Erepulsion) calculated for a cluster of molecules within 25 Å from a reference 
molecule through the CE-B3LYP/6-31G(d,p) model.  All values are expressed as kcal/mol. 
Compound Eelectrostatic Epolarization Edispersion Erepulsion Etotal Elattice 
1 -24.4 -6.1 -56.2 26.8 -59.8 -29.9 
2 -20.8 -5.2 -49.5 23.7 -51.9 -26.0 
 
3.12 Packing similarity study 
The packing similarity was performed in Mercury [68] to differentiate the packing 
arrangements in the crystals of 1 and 2.  The analysis shows that both crystals have some 
similarities in term of their molecular packing, with six out of 15 pairs of molecules found to 
meet the 20% tolerance criterion in both distance and angle deviations and overlap, 
Supplementary Materials Fig. S7.  The r.m.s. deviation for the overlap is about 0.39 Å.  While 
1 and 2 have the same structural framework, major deviations in the precise molecular 
packing are evident. 
 
3.13 Biological activities 
3.13.1 Enzyme inhibitory activity: α-Glucosidase inhibition assay 
Compound 1 was tested for its potential inhibitory activity against the enzyme α-glucosidase 
with the obtained results are listed in Table 10.  The inhibitory activity of 1 was tested at two 
different concentrations, i.e. 22.5 and 45 mM/l.  Compound 1 exhibited a moderate inhibition 
potential activity against α-glucosidase comparing to Acarbose which is the reference 
employed in this study.  The percentage of inhibition for Acarbose at 22 mM/l is two times 
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higher than 1 at 45.0 mM/l.  The increase of concentration of 1 in the assay from 22.5 to 45.0 
mM/l increased the inhibitory percentage by less than 15%. 
 
Table 10 
The inhibitory effects of 1 and Acarbose against the enzyme α-glucosidase 
 concentrations (mM/l) α-glucosidase inhibition (%) 
1 22.5 32.20 
45 47.98 
Acarbose 20 90.60 
 
3.13.2 In vitro anti-inflammatory study: Heat-induced haemolysis 
Compound 1 was also evaluated for its in vitro potential anti-inflammatory activity by heat-
induced haemolysis.  The results summarised in Table 11 showed that 1 exerts low heat-
induced haemolysis inhibition.  When 1 was tested at different concentrations, i.e. 250, 500 
and 1000 mM/l, and the results compared to Indomethacin and Aspirin at 100 mM/l, which 
were the reference compounds in the assay.  The percentage of inhibition of 1 at 1000 mM/l is 
two times less than Aspirin at 100 mM/l.  The increase of concentration of product from 250 
to 1000 mM/l had a weak effect on the increase of heat-induced heaemolysis inhibition 
percentage, i.e. less than a 4% increase. 
 
Table 11 
Effect of 1, Indomethacin and Aspirin on heat induced haemolysis of erythrocyte. 
 concentrations (mM/l) α-glucosidase inhibition (%) 





Indomethacin 100 27.01 
Aspirin 100 34.75 
 
Great attention has been paid to compounds containing a pyridazin-3(2H)-one moiety, due to 
their potential biological activities, such as anti-inflammatory [1-8].  Structure-activity 
relationship studies showed that the alkylation of the lactame function of pyridazin-3(2H)-one 
improves this activity, in agreement with the results obtained for 1.  On the other hand, a 
series of pyridazine analogues was prepared and their potency against α-glucosidase was 
investigated by Chaudhry et al. [9].  The ring-bound oxygen atom forms a hydrogen bonding 
interaction with the α-glucosidase residue Asn246.  Also, the substituents in the N-phenyl ring 
were also important factors [10].  The nature and positional effects of substituents were also 
found highly significant.  These interactions and N-alkylation by 2-ethyl bromoacetate make 1 
more potent: it could be a promising candidate for more potent anti-diabetic drugs. 
 
Conclusions 
Crystallography on a new pyridazinone derivative, 1, shows a planar pyridazinyl ring 
consistent with significant delocalisation of π-electron density over the ring.  A kink observed 
in the conformation of the ethylacetate group does not persist in the optimised, gas-phase 
structure, 1g.  The phenyl analogue of 1, namely 2, exhibits experimental and theoretical 
structures consistent with 1g.  Despite this, the molecular packing of 1 and 2 are distinct with 
differences primarily traced to the influence of the methyl group in 1 which results in a more 
stable overall molecular packing in 1, by ca 4.1 kcal/mol.  Compound 1 shows moderate 
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